Navigation Links
Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects
Date:2/17/2009

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced that it will fund two new especially innovative and high-risk research projects. The Joint Committee of Germany's largest research funding organisation, located in Bonn, has approved funding for two new Reinhart Koselleck Projects. Professor Margit Zacharias, a nanotechnologist from Freiburg, and Professor Reinhard Drner, an atomic physicist from Frankfurt, have each been awarded 1.25 million euros, which they will be able to use flexibly for their projects over the next five years.

"With our Reinhart Koselleck project funding we aim to promote outstanding researchers who have adventurous ideas and are willing to undertake higher-risk research," commented Professor Matthias Kleiner, President of the DFG, during the DFG's Joint Committee session. It was the second time that the Joint Committee has approved funding under this programme, following the first Reinhart Koselleck awards in December 2008, when six researchers were granted Reinhart Koselleck Project funding. The Reinhart Koselleck programme, named after the late renowned historian from Bielefeld, who died in 2006, fills a gap in the DFG's funding programmes and in the German research funding landscape as a whole. "In the past even noted researchers who had wanted to do promising, higher-risk research had almost no way of applying for funding," said the President of the DFG. Since it is usually more difficult to plan especially innovative and high-risk research than is the case for normal research work, only a five-page project outline is required to apply for Reinhart Koselleck Project funding. In addition to the ambitious project ideas, the applicants' proven track records play a crucial role in the review process. "The Koselleck Projects," said Kleiner, "are an enormous vote of confidence that needs to be earned." The DFG's Joint Committee found that these very demanding requirements were met by the project
'/>"/>

Contact: Marco Finetti
marco.finetti@dfg.de
49-228-885-2230
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Genmab Announces Encouraging Preclinical Data for ofatumumab
4. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
5. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
6. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
7. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
8. Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
9. Nycomeds Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies
10. Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia
11. U-M research: New plastic is strong as steel, transparent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
(Date:10/22/2014)... Nuvilex, Inc. (OTCQB: NVLX) – According to ... are living with diabetes, with  that number expected to ... market for diabetes treatments is approximately $500 billion.  ... from pancreatic cancer.  Pancreatic cancer is the fourth most ... the United States , and according to ...
(Date:10/20/2014)... 20, 2014 Mapp Biopharmaceutical,s valiant effort ... therapeutic to fight the Ebola outbreak will make ... the production of pharmaceuticals can be, according to ... that while some may be taken aback by ... with industry knowledge are well aware of the ...
(Date:10/20/2014)... , A major pan-European survey ... delivery of care has revealed changing trends in many ... the provision of healthcare services across the continent. The ... European Gastroenterology (UEG), have been announced today and led ... the burden of GI disorders across Europe ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5
... and to Complete Current Phase 3 Trial of Naturlose(R) ... June 23 Spherix Incorporated (Nasdaq: SPEX ... a provider of technical and regulatory consulting services to ... it has received its first full-scale production batch of ...
... Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced ... once-a-day, oral antibiotic Restanza(TM) (cethromycin), showed that a 14-day ... an inhaled lethal dose of anthrax. All of the ... (the human equivalent dose of 300 mg) of Restanza ...
... VIENNA, Austria, June 23 MIG ... Venture Capital & Private Equity Award,competition, hosted by the industry ... between the,German venture fund and the Austrian biotechnology company as ... Biologicals. , Last Tuesday MIG Fonds ...
Cached Biology Technology:Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 2Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 3Spherix Announces Full-Scale Production of Pharmaceutical Tagatose 4Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 2Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study 3AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 2AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 3
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
(Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
(Date:10/15/2014)... pneumonia in female mice to an enzyme activated by ... more resistant to respiratory infections than males. Now, an ... to bacterial pneumonia in female mice is linked to ... show that this enzyme is ultimately activated by the ... team, lead by Professor Lester Kobzik at the Harvard ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... ecological sustainability of biofuels and the impact of their ... will take place on Friday, Dec. 5, in Panama ... Forests: Trends, Implications and Emerging Alternatives, is sponsored by ... Program in Native Species Reforestation, both joint programs of ...
... "Waterproof" versions of popular varieties of rice, which can ... farmers, fields with flying colors. Several of these varieties are ... certification agencies in Bangladesh and India, where farmers suffer major ... tons of rice per year. This is enough rice to ...
... Department of Plant Biology and Biotechnology at the ... been granted the Danisco Award 2008. She received ... secondary metabolites, which are biologically active substances in, ... has focused on biosynthetic pathways, regulation and transport ...
Cached Biology News:Conference to explore sustainability of biofuels 2From genes to farmers' fields 2From genes to farmers' fields 3The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2
... Trap is specifically designed for efficient ... as DMSO and DMF in the ... refrigeration system set at -5 o ... DMSO, while completely eliminating the risk ...
Thermo Forma provides an array of accessory Racks for the Cryo/CryoPlus 16" Diameter storage system. To maximise inventory capacity a Jumbo Arrowhead configuration is recommended. You may choose betw...
... combine high durability and capacity with unequalled ... mechanism prevents vibration, allowing the unit to ... other part, from the large rubber block ... aluminum platform is designed to last through ...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: